Plasma norepinephrine level in affective disorders. Relationship to melancholia

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Major depressive episode with melancholia is associated with neurobiological alterations.
• Norepinephrine (NE) is a key neurotransmitter in stress response and mood regulation.
• Previous research suggests sympathetic nervous system dysregulation in depression.

Purpose of the Study:

• To investigate plasma norepinephrine levels in different subtypes of depression.
• To compare NE levels between depressed patients and healthy controls.
• To explore the relationship between NE levels, melancholia, and the dexamethasone suppression test (DST).

Main Methods:

• Plasma NE levels were measured in 45 depressed patients and 41 normal controls.
• Patients were categorized based on DSM-III criteria for major depressive episode with melancholia (MDE-MEL), previous melancholia (MDE-PMEL), MDE alone, and dysthymic disorder.
• Bipolar patients with melancholia were also assessed.
• DST was performed on unipolar patients with melancholia.

Main Results:

• Patients with MDE-MEL and MDE-PMEL exhibited significantly higher plasma NE levels than controls.
• Patients with MDE alone and dysthymic disorder showed NE levels comparable to controls.
• Bipolar patients with melancholia had lower NE levels than unipolar depressed patients with similar histories.
• Among unipolar patients with melancholia, DST nonsuppressors had higher lying-down NE values than suppressors.

Conclusions:

• Elevated plasma NE is specific to depressed patients with melancholic features.
• Norepinephrine dysregulation may be linked to the hypothalamic-pituitary-adrenal axis dysfunction in a subgroup of depressed patients.
• These findings highlight distinct neurobiological profiles in depressive subtypes.